- Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma. Francis, L.K., Alsayed, Y., Leleu, X., Jia, X., Singha, U.K., Anderson, J., Timm, M., Ngo, H., Lu, G., Huston, A., Ehrlich, L.A., Dimmock, E., Lentzsch, S., Hideshima, T., Roodman, G.D., Anderson, K.C., Ghobrial, I.M. Clin. Cancer Res. (2006)